Measles, Mumps, and Rubella (MMR)
GPTKB entity
Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
injection
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:availableOn |
combination with varicella (MMRV)
|
| gptkbp:boosterRecommended |
no
|
| gptkbp:broadcastOn |
two doses
|
| gptkbp:contains |
live attenuated viruses
|
| gptkbp:contraindication |
pregnancy
severe immunodeficiency |
| gptkbp:developedBy |
gptkb:Maurice_Hilleman
1971 |
| gptkbp:firstDoseAge |
12-15 months
|
| https://www.w3.org/2000/01/rdf-schema#label |
Measles, Mumps, and Rubella (MMR)
|
| gptkbp:prevention |
gptkb:congenital_rubella_syndrome
|
| gptkbp:protectedBy |
gptkb:measles
gptkb:mumps gptkb:rubella |
| gptkbp:recommendation |
children
|
| gptkbp:routeOfAdministration |
subcutaneous
|
| gptkbp:secondDoseAge |
4-6 years
|
| gptkbp:sideEffect |
fever
swelling at injection site mild rash |
| gptkbp:storage |
2-8°C
|
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:United_States_(routine_vaccination)
|
| gptkbp:bfsLayer |
7
|